Mwandishi:
ULY CLINIC
Mhariri:
Dkt. Peter A, MD
7 Novemba 2021 09:02:45
Je, p2 ina madhara gani?
Postinor 2 huwa salama yenye uwezo wa kufanya kazi ya kuzuia mimba kama itatumika kwa dozi inayotakiwa na kwa wakati. Hata hivyo inaweza sababisha baadhi ya maudhi kama vile kichefuchefu, maumivu ya kichwa, matiti na tumbo n.k.
Maudhi ya postinor 2
Maudhi ya p2 ni pamoja na;
Kichefuchefu
Maumivu ya kichwa
Maumivu ya titi
Maumivu ya tumbo
Kuharisha
Kizunguzungu
Uchovu wa mwili
Mabadilikoya period
Mabadiliko ya period
Hedhi nzito
Hedhi nyepesi
Kuchelewa kwa period
Kuanza mapema kwa period
Kama period yako itachelewa zaidi ya siku 5, kuna uwezekano kuwa una ujauzito.
Wakati gani uwasiliane na daktari?
Dalili ambazo zikufanye uwasiliane na daktari haraka ni;
Kupata maumivu makali ya tumbo la chini
Mzio mkali mfano ngozi kubadilika rangi, kupata melenge kwenye ngozi, kuvimba midomo n.k
Period nzito au nyepesi au isiyo ya kawaida
Kama una hofu ya kuwa una ujauzito
ULY CLINIC inakushauri uwasiliane na daktari wako kwa ushauri na tiba kabla ya kuchukua hatua yoyote ile baada ya kusoma majibu haya.
Kupata ushauri zaidi au tiba kutoka kwa daktari wa ULY CLINIC bofya hapa au tumia linki ya Pata tiba
Imeboreshwa,
7 Novemba 2021 09:45:56
Rejea za mada hii
Postinor. https://postinorpill.com/faq/#:~:text=Usually%20taking%20an%20POSTINOR%20pill,spotting%20until%20your%20next%20period. Imechukuliwa 07.11.2021
Edgren RA, et al. Nomenclature of the gonane progestins. Contraception. 1999 Dec;60(6):313.
Sitruk-Ware R: New progestagens for contraceptive use. Hum Reprod Update. 2006 Mar-Apr;12(2):169-78. Epub 2005 Nov 16.
Kahlenborn C, et al. Mechanism of action of levonorgestrel emergency contraception. Linacre Q. 2015 Feb;82(1):18-33. doi: 10.1179/2050854914Y.0000000026.
Kook K, et al. Pharmacokinetics of levonorgestrel 0.75 mg tablets. Contraception. 2002 Jul;66(1):73-6.
Sambol NC, etal. Pharmacokinetics of single-dose levonorgestrel in adolescents. Contraception. 2006 Aug;74(2):104-9. doi: 10.1016/j.contraception.2006.01.011. Epub 2006 Jun 16.
Natavio M, et al. Pharmacokinetics of the 1.5 mg levonorgestrel emergency contraceptive in women with normal, obese and extremely obese body mass index. Contraception. 2019 May;99(5):306-311. doi: 10.1016/j.contraception.2019.01.003. Epub 2019 Jan 28.
Shohel M, et al. A systematic review of effectiveness and safety of different regimens of levonorgestrel oral tablets for emergency contraception. BMC Womens Health. 2014 Apr 4;14:54. doi: 10.1186/1472-6874-14-54.